Yan Wang is an Assistant Professor of Epidemiology at the University of Florida (UF). Her research interests focus on leveraging advanced technologies and methods (e.g., wearable sensors, ecological momentary assessment/EMA) to improve the understanding of etiology and consequences of substance use (e.g., alcohol, medical marijuana). Dr. Wang is also Associate Director of the Southern HIV and Alcohol Research Consortium (SHARC, U24 AA022002, PI: Cook) Center at UF, which focuses on improving health among persons living with HIV in Florida. She also serves as the clinical core lead of the Consortium for Medical Marijuana Clinical Outcomes Research, which is a new consortium established in 2019 by the Florida Statute to provide infrastructural support for statewide research on medical marijuana and its clinical outcomes. Dr. Wang is currently involved in three NIH projects focusing on alcohol use among persons with HIV that involve the use of wrist-worn alcohol biosensor (R21 AA027191, PI: Wang; P01AA029547, MPIs: Naar & MacDonald; P01AA029543, MPIs: Cook & Cohen), and she has three pending projects also involve the use of these biosensors. She is also the PI of a newly funded R01 project (R01AG071729, PI: Wang) which will utilize technology-based assessments to investigate the real-time and long-term effects of medical marijuana on older adults with chronic pain. Dr. Wang has also been contributing as Co-I on several NIH funded research projects such as a large NIAAA project examining experimentally-induced reduction in alcohol use and its impact on cognitive function (U01 AA020797-06), an NIDA funded project on health effects of marijuana use (R01 DA042069) among persons living with HIV, and several COVID/Alzheimer’s supplements of these projects.

Substance use and HIV; biosensors; ecological momentary assessment